SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-028308
Filing Date
2018-11-08
Accepted
2018-11-08 08:30:28
Documents
3
Period of Report
2018-11-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kura-8k_20181108.htm 8-K 31776
2 EX-99.1 kura-ex991_6.htm EX-99.1 17115
3 GRAPHIC gj1z1c5fgnyg000001.jpg GRAPHIC 4451
  Complete submission text file 0001564590-18-028308.txt   56498
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 181168294
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences